Physician profile
Ann S Hatfield
NPI 1295898583
$894.86
in general payments reported to CMS, 2019-2025
20 companies · $88.85 in 2025
The $88.85 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $125 · 2021: $234 · 2022: $50.82 · 2023: $50.99 · 2024: $74.91 · 2025: $88.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $169.82 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.34 | 2019-2023 | |
| Hologic Sales and Service, LLC | $105.28 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Allergan, INC. | $93.94 | 2019-2020 | |
| Therapeuticsmd, INC. | $81.01 | 2019-2021 | |
| Astellas Pharma US INC | $44.49 | 2020-2024 | Veozah |
| Mayne Pharma Commercial LLC | $33.71 | 2025 | |
| Lupin INC. | $31.26 | 2019 | |
| Merck Sharp & Dohme LLC | $29.75 | 2019-2020 | |
| Coopersurgical, INC. | $29.25 | 2019-2023 | Paragard T 380a |
| Exact Sciences Corporation | $20.66 | 2025 | Cologuard Collection Kit |
| Millicent US INC | $19.63 | 2020 | |
| Daiichi Sankyo INC. | $19.34 | 2025 | Datroway |
| Evofem Biosciences, INC. | $19.30 | 2021 | |
| Array Biopharma INC | $18.92 | 2024 | Braftovi, Tukysa, Mektovi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $18.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.37 | 2024 | Gilotrif |
| Myovant Sciences INC. | $13.97 | 2021 | |
| Roche Diagnostics Corporation | $12.06 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Hatfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.